Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
225 hedge funds and large institutions have $1.76B invested in Exact Sciences in 2016 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 66 increasing their positions, 65 reducing their positions, and 18 closing their positions.
250% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 18
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
49% more capital invested
Capital invested by funds: $1.18B → $1.76B (+$583M)
24% more funds holding
Funds holding: 181 → 225 (+44)
2% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 65
11% less call options, than puts
Call options by funds: $37.2M | Put options by funds: $41.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$40.3M |
| 2 |
State Street
Boston,
Massachusetts
|
+$35.9M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$34.1M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$15.6M |
| 5 |
D.E. Shaw & Co
New York
|
+$15.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$58.7M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$34.1M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$32.3M |
| 4 |
O
OppenheimerFunds
New York
|
-$26.6M |
| 5 |
O
OrbiMed
New York
|
-$18.1M |
EXAS Hedge Fund Activity: Q3 2016 in Review
225 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2016, worth a combined $1.76B — up 49% from $1.18B a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new EXAS positions and 18 closed out — a net gain of 45 holders — while 66 added to existing stakes and 65 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $40.3M. The largest seller was Millennium Management, cutting an estimated $58.7M.
- 225 institutional investors held Exact Sciences (EXAS) as of Q3 2016, up from 181 in Q2 2016.
- Funds reported $1.76B of Exact Sciences stock for Q3 2016, up 49% quarter-over-quarter.
- 63 funds opened new Exact Sciences positions in Q3 2016 and 18 closed out, a net change of +45 holders.
- The largest Exact Sciences buyer in Q3 2016 was Gilder Gagnon Howe & Co, an estimated $40.3M added.
- The largest Exact Sciences seller in Q3 2016 was Millennium Management, an estimated $58.7M sold.
Based on aggregated 13F filings for Q3 2016.